Our comprehensive approach to neuro-oncology testing focuses on the best outcomes for the patient. By performing immunohistochemical, molecular, and cytogenetic analysis on all patients, our testing approach provides a more complete assessment and enables a clearer picture of diagnosis, prognosis, and treatment options.
Understanding specific molecular markers not only facilitates a diagnosis that meets classification guidelines, but it can also guide treatment decisions and therapeutic timelines. Attaining broad molecular and cytogenic information is also needed to select the most appropriate treatment options, whether standard, off-label, or clinical trial.
Fill out the form below and one of our specialists will be in touch.